Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation. by Kobayashi, Maki et al.
Title
Decrease in topoisomerase I is responsible for activation-
induced cytidine deaminase (AID)-dependent somatic
hypermutation.
Author(s)
Kobayashi, Maki; Sabouri, Zahra; Sabouri, Somayeh;
Kitawaki, Yoko; Pommier, Yves; Abe, Takaya; Kiyonari,
Hiroshi; Honjo, Tasuku
CitationProceedings of the National Academy of Sciences of theUnited States of America (2011), 108(48): 19305-19310
Issue Date2011-11-29
URL http://hdl.handle.net/2433/152359





Classification: BIOLOGICAL SCIENCES, Genetics. 
 
Decrease in topoisomerase I is responsible for AID-dependent somatic hypermutation 
 
Maki Kobayashi, Zahra Sabouri, Somayeh Sabouri, Yoko Kitawaki, Yves Pommier*, Takaya Abe†, 
Hiroshi Kiyonari†, and Tasuku Honjo1 
 
Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, 
Yoshida Sakyo-ku, Kyoto 606-8501, Japan. 
*Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, 
Bethesda, MD 20892-4255, USA. 
†Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental 
Biology, 2-2-3 Minatojima Minami, Chuou-ku, Kobe 650-0047, Japan 
 





Somatic hypermutation (SHM) and class-switch recombination (CSR) of the immunoglobulin gene 
require both transcription of the locus and the expression of activation-induced cytidine deaminase 
(AID). During CSR, AID decreases the amount of topoisomerase I (Top1); this decrease alters the 
DNA structure and induces cleavage in S region. Similarly, Top1 is involved in 
transcription-associated mutation (TAM) at dinucleotide repeat in yeast and in triplet repeat 
contraction in mammals. Here, we report that the AID-induced decrease in Top1 is critical for SHM. 
Top1 knockdown or haploinsufficiency enhanced SHM, whereas Top1 overexpression 
down-regulated it. A specific Top1 inhibitor, camptothecin, suppressed SHM, indicating that Top1’s 
activity is required for DNA cleavage. Nonetheless, suppression of transcription abolished SHM, 
even in cells with Top1 knockdown, suggesting that transcription is critical. These results are 
consistent with a model proposed for CSR and triplet instability, in which transcription-induced 
non-B structure formation is enhanced by Top1 reduction, and provides the target for irreversible 
cleavage by Top1. We speculate that the mechanism for transcription-coupled genome instability was 




The immunoglobulin (Ig) locus undergoes two types of genetic alteration, somatic hypermutation 
(SHM) and class switch recombination (CSR), to generate antibody memory against given antigens 
when B lymphocytes are stimulated by pathogens. Both SHM and CSR depend on the expression of 
activation-induced cytidine deaminase (AID) (1, 2) and transcription of the target Ig loci (3-6).  
AID is responsible for introducing DNA cleavage in the variable (V) region and the switch 
(S) region of the Ig locus for initiating SHM and CSR, respectively (7-10). AID’s DNA cleavage 
activity is associated with its amino-terminal region, because mutations at the carboxyl (C)-terminus 
abolish CSR without affecting SHM and DNA cleavage in the S region (7, 11, 12). It is likely that the 
C-terminal region of AID is required for the recombination of the cleaved S region ends. Thus, AID 
carries out two separate functions with a single catalytic center located in the middle of the protein. 
Under normal conditions, AID is only expressed in activated B cells and introduces genetic 
alterations in the Ig gene. However, Ig genes are not the only targets of AID (13, 14). Indeed, AID is 
involved in Ig-c-myc chromosomal translocation, causing malignant tumors (15, 16). More recently, 
certain pathogens were reported to induce the activation of AID, which may cause tumorigenesis over 
the long-term (17-20). 
Using an artificial construct to monitor CSR and SHM, positive correlations between 
transcription levels and the efficiencies of CSR and SHM have been demonstrated (21, 22). 
Transcription-associated genomic instability has been extensively studied in a number of systems 
(23). One finding of these studies is that the frequency of mutations, including base replacements and 
deletions, caused by transcription-associated mutagenesis (TAM) increased in parallel with the 
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transcription enhancement of the specific loci. Recently, 2-5-base deletions by TAM in two different 
loci in yeast, Can1 and Lys2, were shown to depend on topoisomerase I (Top1) (24, 25). In the 
absence of Top1, TAM was decreased, drastically affecting deletions, with less effect on the number 
of base replacements. The deletion of 2-5 bases takes place frequently at hot spots that contain 
dinucleotide (AT) repeats. Transcription is also required for the contraction or expansion of triplet 
repeats; these changes are associated with human diseases, including Huntington’s disease, myotonic 
dystrophy type 1, and spinocerebellar ataxia (26). Triplet repeats are believed to form non-B 
structures caused by the excessive negative superhelicity induced by active transcription. A recent 
report provided evidence that Top1 introduces irreversible cleavage at triplet repeats in a 
transcription-dependent manner (27). 
Normally, Top1 corrects the transcription-induced excessive supercoiling by nicking, 
covalently binding to DNA through phospho-tyrosine bond, rotating DNA along the helix, and finally 
religating the nicked end (28). When the transcription rate exceeds the capacity of Top1, excessive 
negative supercoiling accumulates at the rear of the transcription machinery, increasing the chance of 
non-B structure formation at repeat or palindrome-rich regions (29). Top1 cuts non-B DNA and forms 
a DNA-bound intermediate, but cannot rotate around the helix, resulting in irreversible cleavage and 
mutagenesis (27). Thus, the appropriate balance between the transcription rate and Top1 activity 
appears to be critical for maintaining genome stability. In agreement with this assumption, a decrease 
in Top1 in mammalian cells induces genome instability (30, 31). 
We recently showed that AID reduces the protein level of Top1, which induces CSR (32). 
Furthermore, we showed that artificially reduced levels of Top1 also enhance CSR in CH12F3-2A B 
lymphoma cells and splenic B cells. This effect is associated with increased DNA cleavage in the S 
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region. In addition, camptothecin (CPT), a specific inhibitor of Top1 catalytic activity, blocks DNA 
breaks and CSR without affecting transcription of the S region. 
Here we report that AID decreases the level of Top1 in SHM-proficient cells and that 
further reduction of the Top1 protein level by knockdown or haploinsufficiency augments SHM. By 
contrast, the overexpression of Top1 down-regulated SHM frequency. Furthermore, a concurrent, 
gradual decrease in the transcription of the target locus reduced SHM efficiency, regardless of Top1 
knockdown. Finally, SHM efficiency was inhibited by a low dose of CPT. These results collectively 
indicate that the AID-induced genetic alterations CSR and SHM share, at least in part, the 




Decrease in Top1 increases the frequency of SHM in B cells 
Previously, we showed that AID decreases the Top1 level in CH12F3-2A cells, which undergo CSR 
but not SHM (32). To confirm the AID-induced reduction of Top1 in SHM-proficient cells, we used 
AID-knockout BL2 cells (human Burkitt’s lymphoma line) (33) that express a fusion protein of AID 
and the estrogen receptor (ER) binding domain (BL2-AID–/–AIDER). As expected, the amount of 
Top1 clearly decreased, by about half in the BL2-AID–/– AIDER cells, 6 hours after stimulation with 
4-OHT (Fig. 1A). AIDER activation simultaneously caused the accumulation of SHM (Table 1A-B).  
We next examined the effect of Top1 knockdown on SHM by transfecting an siRNA oligo 
that suppresses hTop1 (hTop1#3) or control oligos with the same GC content. The Top1 level was 
efficiently suppressed by the siRNA (Fig. 1B), and accompanied by an increase in SHM frequency in 
the expressed V (VH4-39-JH5) gene sequence (33) (Table 1A). However, the difference between the 
Top1-knockdown and the control samples was not large enough to demonstrate statistical 
significance. The base substitution pattern of the Top1-knockdown sample was similar to that of the 
control. The base substitution profiles were stable throughout the mutation analyses in the present 
study (Supplementary Table 1). Since the SHM augmentation by Top1 knockdown was not 
statistically significant in the V region, we examined the SHM frequency of the Sμ region because the 
mutation frequency in this region is AID-dependent and generally higher than in the V region (9). In 
the Sμ region, the SHM frequency was significantly increased by Top1 knockdown compared with 
the control oligo-transfected sample (Table 1B). 
 To examine the effect of Top1 reduction on SHM in vivo, we generated a Top1 conditional 
knockout mouse with a floxed exon 15 (Top1f), which is detected as a 6.2-kb HindIII fragment by the 
3’ Probe A (Fig. 1C-D). Top1 heterozygotes (Top1–/+) were generated by crossing Top1f/+ mice with 
CAG-Cre transgenic mice. Although the exon 15 deletion should produce a shorter Top1 protein, the 
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heterozygotes contained half the amount of Top1 as wild type (WT), probably due to instability of the 
mutant mRNA or protein (Fig. 1E). We next examined the effect of the Top1 haploinsufficiency on 
SHM in vivo. Germinal center B cells were isolated from the Peyer’s patches of heterozygotes and 
WT littermates, and their genomic DNA was extracted for SHM analysis. The SHM frequency at the 
VHJ558-JH4 region was about 2-fold higher in the Top1 heterozygotes than in the WT littermates, 
with high statistical significance (Table 1C). These results clearly indicate that the Top1 reduction 
enhances SHM. Note that the mutation frequency of the Top1-decreased BL2 cells was similar to that 
of control oligo-transfected cells without AID activation (Table 1A-B), indicating that the Top1 
reduction alone does not induce SHM. 
 
Top1 over-expression suppresses SHM 
To further confirm Top1’s involvement in SHM, we used a Top1-deficient P388/CPT45 subline, 
which was previously established from the mouse B-cell lymphocytic leukemia line P388, by 
selection in the presence of 45 μM CPT (34, 35). The P388/CPT45 cells actually expressed an 
extremely low level of Top1 of the normal size (Fig. 2A, arrow 1) and a low amount of aberrant Top1 
of about 135 kDa (Fig. 2A, arrow 2), indicating that the P388/CPT45 cells were Top1 insufficient but 
not completely deficient. P388 cells contain rearranged forms of the Ig κ-chain and heavy-chain loci, 
but do not express Ig on their surface, which we confirmed by RT-PCR and surface staining (36). 
Nonetheless, the expression level of μ-germline transcripts from the Iμ promoter was comparable 
among the P388, P388/CPT45, and CH12F3-2A cells (Fig. 2B). It is therefore likely that exogenous 
AID expression induces SHM in the 5’-flanking region of the Sμ core sequence, although P388 and 
P388/CPT45 cells do not express endogenous AID (Fig. 2A, arrow 4). AIDER was retrovirally 
introduced into both the parental P388 and the P388/CPT45 cells (Fig. 2A, arrow 5). When AIDER 
was activated by adding 4-OHT, the SHM frequency was significantly higher in the 
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P388/CPT45-AIDER cells (2.56 x 10-4) than in the P388-AIDER cells (0.71 x 10-4), in agreement 
with the above observations that the Top1 reduction enhances SHM (Table 2A). 
 To further confirm the critical role of the Top1 protein level in determining the SHM 
frequency, GFP-fused human Top1 (GFP-hTop1) was introduced into the Top1-insufficient 
P388/CPT45-AIDER cells (Fig. 2A, arrow 3). The expression level of GFP-hTop1 in the 
P388/CPT45-AIDER cells was much higher than their endogenous Top1, and was similar to that of 
Top1 in the parental P388-AIDER cells. The SHM frequency in the Sμ region was drastically reduced 
(2.2 x 10-4) in the GFP-hTop1-supplemented P388/CPT45-AIDER cells compared to the control 
GFP-transfected P388/CPT45-AIDER cells (6.3 x 10-4) (Table 2B). Although hTop1 
supplementation in the P388/CPT45-AIDER cells reduced the SHM frequency, the cell proliferation 
rate was hardly affected, suggesting that the reduction in SHM frequency was not due to a change in 
the cell-proliferation rate (Fig. 2C). 
 
SHM augmentation by Top1 reduction depends on transcription 
Since transcription of the target locus is required for SHM and the efficiency of transcription 
correlates with SHM frequency, it was important to examine whether the Top1 reduction-associated 
SHM augmentation was dependent on transcription. For this purpose, we used NTZ cells, which is 
NIH3T3 cells carrying the construct “pI”, tetracycline(tet)-repressible GFP with a premature stop 
codon (22). An AIDER transfectant of NTZ (Figure 3A) accumulates reversion mutations at the stop 
codon in GFP upon 4-OHT addition, and allows quick SHM detection by GFP reversion expression 
(37).  
 To confirm that the Top1 reduction increases SHM even in non-B cells, NTZ-AIDER 
fibroblast cells were transfected with Top1 siRNA oligos (mTop1#35 and #97) or a control oligo 
sequence, followed by stimulation with 4-OHT. AIDER activation by 4-OHT induced a decrease in 
 9 
Top1 in NTZ cells, and the Top1 protein expression was further reduced by the two siTop1 oligos (Fig. 
3B). The GFP reversion frequency increased from 0.84% in the control to 1.08% (mTop1 #35) or 
1.22% (mTop1 #97) (Fig.3C), whereas the 4-OHT non-stimulated samples had a very low GFP 
expression frequency (0.07-0.19%). Consistent with these findings, Top1 knockdown increased the 
SHM frequency, as assessed by a sequence comparison of the GFP gene, from 2.9 x 10-3 (control) to 
4.5 x 10-3 (mTop1#35) or 4.7 x 10-3 (mTop1#97) (Table 3). The difference was highly statistically 
significant.  
 The NTZ-AIDER system allows the transcriptional activity of the SHM target GFP to be 
modulated by the titration of tet. To test whether transcription of the target was dominant over the 
Top1 reduction for SHM, the GFP reversion was examined in NTZ-AIDER cells with Top1 
knockdown in the presence of serially diluted concentrations of tet (Fig. 3D). NTZ-AIDER cells 
treated with mTop1#35 or mTop1#97 showed approximately doubled rates of GFP reversion (0.9 and 
0.95%) compared with the control (0.55%) in the absence of tet, while the GFP reversion gradually 
declined, reaching almost zero at 50 ng/ml tet, regardless of the Top1 knockdown. These results 
clearly indicate that transcription has the dominant effect in SHM, which is also true for TAM, 
CAG-repeat deletion, and CSR (21, 24, 25, 27). 
 
Top1 activity required for SHM in fibroblasts and B cells 
We next examined the requirement of Top1 activity for SHM. The complete deletion of Top1 in 
mammals is lethal at the pre-implantation stage (38). We therefore investigated the effect of CPT on 
SHM in NTZ-AIDER cells. The addition of 30 nM CPT strongly inhibited the GFP reversion induced 
by 4-OHT in the NTZ-AIDER cells (Fig. 4A). The DNA sequence determination of the GFP-coding 
region confirmed that the mutation frequency was indeed reduced by the addition of 30 nM CPT, to 
less than one-fourth its level without CPT (6.1 x 10-4 vs. 1.5 x 10-4) (Table 4A). This SHM reduction 
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was not due to cell death or the inhibition of target transcription, because 96 and 98% of the 30 nM 
CPT-treated and non-treated cells, respectively, remained alive (Fig. 4B), and transcription of the 
target GFP was not changed by the 30 nM CPT treatment (Fig. 4C). 
To confirm the inhibitory effect of CPT on the SHM in B cells, we established a sensitive 
SHM assay in B cells to avoid the side effects of CPT during long-term incubation. First, we 
expressed a C-terminally truncated form of AID (JP8Bdel) fused with ER in BL2 cells, because 
JP8Bdel has 4-fold stronger DNA-cleavage activity and SHM efficiency than WT AID (7). In fact, 
stimulation of the BL2 cells expressing JP8BdelER (BL2-JP8BdelER) with 1 μM 4-OHT for 3 hours 
decreased the Top1 protein amount to about a half of the control level (Fig. 4D), which is much faster 
than the rate obtained with AIDER (Fig. 1A). Second, we chose the S region as the target, because it 
is 5 times more frequently mutated than the V region (7). Using this system, we observed 7.2 x 10-4 
mutations in the 5’-flanking region of the Sμ region 24 hours after the addition of 4-OHT, while 
endogenous WT AID in BL2 cells induced only 1.7 x 10-4 mutations (Table 4B). When 30 nM CPT 
was added to the culture one hour before the activation of JP8BdelER by 4-OHT, the SHM frequency 
was reduced to 3.5 x 10-4, although some cell death was induced in the BL2 cells (20% at 30 nM CPT). 
Since CPT drastically reduced the SHM in two different systems, we conclude that Top1 activity is 
required for SHM, as for the base deletion by TAM and the DNA cleavage in CSR. 
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Discussion 
Involvement of Top1 in SHM 
 In the present study, we showed that the AID-dependent decrease in Top1 induces SHM, 
and that additional Top1 knockdown augments SHM further, as previously shown for CSR (32). By 
contrast, Top1 over-expression suppresses the AID-dependent SHM. SHM frequency is thus 
inversely correlated with Top1 level. SHM also depends on the catalytic activity of Top1, because 
CPT drastically reduced SHM. From these lines of evidence, Top1 itself may make an irreversible 
cleavage at the transcription-associated non-B DNA structures in the V region, whose formation is 
enhanced by the partial Top1 deficiency. Moreover, the SHM efficiency quantitatively correlates with 
both the target’s transcription level (22) and the Top1 reduction by knockdown. Thus, transcription 
enhancement and Top1 reduction have the same augmenting effect on the accumulation of the DNA 
superhelicity, which enhances the non-B structure formation.  
 
Transcription-induced non-B structure formation 
Transcription is by its nature dangerous to the maintenance of genome integrity (23). In 
eukaryotes, transcription requires disassembly of the tightly packed chromatin structure and 
chromatin reassembly (39), accompanied by the exposure of naked DNA and R-loop formation (40). 
Furthermore, during transcription, a local distortion of the DNA superhelix is created, positive in the 
front and negative in the rear of the transcription machinery (41), that enhances the non-B structure 
formation (42). 
Because of these effects, excessive transcription is associated with mutations, deletions, 
recombination, and other genetic events. The transcription-induced non-B DNA structure formed at 
repetitive or palindromic sequences is considered the major risk for genetic instability (41, 43). A 
model linking transcription and non-B structures has been proposed for triplet repeat 
contraction/expansion, which is associated with human diseases such as Huntington’s disease (26). 
Dinucleotide repeat sequences are hot spots for deletions and mutations in TAM (24, 25). The 
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transcription of target loci is also required for physiological recombination and mutational events, 
such as meiotic recombination, VDJ recombination, CSR, and SHM, although not all of these event 
may require the non-B structure formation (4, 21, 44, 45).  
 
Top1 reduction augments the non-B structure formation and causes irreversible cleavage 
Since Top1 regulates the DNA superhelical density at the transcription sites, it is reasonable 
to suppose that transcription-induced non-B structure formation is enhanced by Top1 reduction. 
Gangloff et al (46) showed that the loss of Top1 increases genetic instability in yeast and suggested 
that CSR may depend on transcription-induced non-B configuration in the repetitive sequences of the 
Sα region during CSR. Recently, Top1 was also shown to be involved in the transcription-induced 
triplet repeat deletion in mammals (27). Top1 knockdown causes an increase in triplet contraction, In 
addition, suppression of the enzymes which remove DNA-bound Top1 also enhances triplet 
contraction. The results suggest that Top1 may cut non-B structures but cannot rotate around the helix, 
which results in irreversible cleavage. Furthermore, recent reports about TAM in yeast have shown 
that the 2-5-base deletion at dinucleotide repeats is almost completely dependent on the catalytic 
activity of Top1 (24, 25). Chromatin immunoprecipitation without crosslinking reagent demonstrated 
that Top1 is covalently binding to the target gene in a transcription-dependent manner, suggesting that 
Top1 is responsible for the DNA cleavage in TAM. These results are consistent with the observation 
that Top1 reduction causes genetic instability in mammalian cells. The long-term culture of 
P388/CPT45 cells carrying a low level of Top1 causes the accumulation of γH2AX focus formation 
on various chromosomes (31). Extensive chromosomal translocation is also observed in this cell line. 
We showed that AID reduces Top1, to initiate CSR. Since the S region consists of repetitive and 
palindromic sequences, the transcription–induced excessive negative superhelix induces non-B 
structures, leading to irreversible cleavage by Top1 (32).  
 
Target determination of SHM 
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Triplet contraction in mammalian cells and TAM in yeast may depend on non-B 
structure-associated irreversible cleavage by Top1, because deletions take place in regions of triplet 
repeats and dinucleotide repeat hotspots, respectively. The S region also contains many repeats that 
appear to form non-B structures. Although the V region does not contain many repeated sequences, a 
computer analysis indicated that the V region can form non-B-type structures, especially stem-loops, 
under excessively negative supercoiled conditions (47, 48). The GFP sequence can also form 
stem-loop structures (http://mfold.rna.albany.edu/?q=DINAMelt/Quickfold).  
Although AID targets are not absolutely limited to Ig loci, they are not random, because 
there are several preferred mutated loci in the genome (13, 14). Non-B DNA structure formation may 
be required for the DNA cleavage in SHM. However, it may not be sufficient to explain all the 
DNA-cleavage loci targeted by AID, because not all repetitive sequences seem to accumulate 
mutations after AID activation in vivo. AID targets appear to be determined by a combination of cis 
(DNA structure) and trans (DNA-binding proteins) factors. We previously showed that histone 
modification H3K4 trimethylation in the S region is essential for DNA cleavage in CSR (49). H3K4 
trimethylation is an important marker for meiotic recombination and VDJ recombination (50, 51). 
Thus, it will be important to examine whether other AID target loci have non-B-prone sequences or 
not. It will also be interesting to investigate whether H3K4 trimethylation is required for SHM. 
 
Evolution of adaptive immunity 
 SHM, CSR, TAM, and triplet repeat contraction may all share a DNA-cleavage 
mechanism: (a) non-B structure formation regulated by the Top1 protein level and the locus 
transcription level and (b) irreversible cleavage by Top1. Thus, AID probably adopted the basic 
mechanism of transcription-coupled genome instability to make DNA cleavage in immunoglobulin 
locus, when adaptive immunity evolved in vertebrates. Such an evolutionary origin makes it 
inevitable that AID targets are not absolutely specific to Ig loci. However, the subsequent processes 
for inducing SHM and CSR appear to be different from those of TAM with dinucleotide repeat hot 
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spots and triplet repeat expansion/contraction. For example, triplet contraction/expansion does not 
appear to be AID-dependent. It is notable that Top1 reduction alone does not cause SHM unless AID 
is activated. Since we assume that AID edits a microRNA to reduce the translation of Top1 mRNA, 
the edited miRNA may activate another functional protein necessary for the DNA cleavage or repair 
step in SHM (32). 
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Materials and Methods 
Cells and reagents 
BL2-AID–/– AIDER cells were generated by transfecting the human Burkitt’s lymphoma-derived 
BL2 cell subclone, BL2-AID–/– (33) with AIDER (52). BL2-JP8BdelER was generated by 
transfecting BL2 cells with JP8BdelER (7). NTZ cells (37) were infected with an AID-ER-expressing 
retrovirus to generate NTZ-AIDER cells. P388 and P388/CPT45 cells (35) were infected with 
pFB-AIDER-IRES-puro for SHM analysis. P388/CPT45-AIDER was transfected with linearized 
EF-EGFP or EF-EGFP-hTop1 plasmid by electroporation, selected with G418 for 6 days, and sorted 
by GFP fluorescence with a FACS ARIA-II (BD). CPT was purchased from Calbiochem and 
dissolved in dimethylsulfoxide (DMSO). 
Human Top1 expression vecto 
The EGFP gene (Clontech) was fused to the N-terminus of the human Top1 (hTop1) coding region in 
the pBlueScript vector (Promega). The EGFP-hTop1 cassette was then inserted between the 
SmaI-XbaI sites of pEF-BOS (53). As the control, EGFP alone was also cloned into pEF-BOS. 
Top1 knockdown 
For the knockdown of Top1 in BL2-AID–/–AIDER cells, the Stealth siRNA oligo hTop1#3 
(HSS110895, Invitrogen) was electroporated by the Nucleofector ™ 96-well Shuttle™ system 
(Lonza). To achieve the knockdown in NTZ-AIDER cells, mTop1#35 (Top1-MSS212035) and 
mTop1#97 (MSS278497) were transfected into the cells using the Lipofectamine™ RNAiMAX 
Transfection Reagent (Invitrogen) following the manufacturer’s instructions. Stealth RNAi Negative 
Control Low or Med GC (Invitrogen) was used as a control. All the sequences of the siRNA oligos 
are shown in Supplementary Table 2A. 
Top1 knockout mouse 
The conditional knockout mice (RIKEN Accession number CDB0799K: 
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http://www.cdb.riken.jp/arg/mutant%20mice%20list.html) with a floxed exon 15 of the Top1 locus 
were generated by the Laboratory for Animal Resources and Genetic Engineering, RIKEN, Center 
for Developmental Biology (Kobe, Japan), and maintained and used at the Institute of Laboratory 
Animals, Graduate School of Medicine, Kyoto University, according to approved protocols for 
animal experiments. The genotype of the floxed allele was confirmed by Southern blotting using 
Probe A, amplified with the primers 3’Probe-F and 3’Probe-R. Heterozygotes of the Top1 floxed 
allele with the neomycin-resistance gene (Top1fl/+) were crossed with CAG-Cre mice to obtain the 
exon 15-deleted allele (Top1–/+). The CAG-Cre mice (B6.Cg-Tg(CAG-Cre)CZ-MO2Osb, produced 
by Dr. Masaru Okabe, Osaka University, Japan) were provided by the RIKEN BRC through the 
National Bio-Resource Project of the MEXT, Japan. Wild-type C57BL/6 mice were purchased from 
CLEA Japan. Genotypes of the compound mice were determined by genomic PCR with KOD FX 
(TOYOBO). The germinal center B cells from the Peyer’s patches of 16- to 25-week-old mice were 
sorted by FACS Aria II after staining with a mixture of FITC-labeled PNA (Vector Laboratories), 
CD95-APC (e-Bioscience), and B220-PE (e-Bioscience). The PNA+B220+ population was sorted 
from mice of litter #1, and the PNA+CD95+B220+ population was recovered from those of litters #2 
and #3. 
Other methods 
To analyze the SHM frequency, KOD Plus Neo (TOYOBO), Pyrobest (TaKaRa), or PrimeStar 
(TaKaRa) was used to amplify the regions. The obtained PCR fragments were cloned into the 
pGEM-T easy vector (Promega) or pBlueScript (Stratagene). The BigDye (ABI) cycle sequencing kit 
and ABI7700 genetic analyzer were used for sequencing. Viral infection, Western blotting, 
measurement of Western blotting signals, and quantitative RT-PCR were performed as previously 
described (32). The primer sequences for cloning or genotyping and the antibodies used in Western 
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Figure Legends 
Figure 1. Top1 reduction by AID activation, knockdown, and haploinsufficiency 
(A) Top1 protein levels in BL2-AID–/–AIDER cells in the presence of the indicated concentration of 
4-oxyhydtroxy-tamoxifen (4-OHT) for the time intervals shown above. Western blots with anti-Top1 
and anti-actin antibodies are shown below. Each sample was loaded in two lanes and the protein 
amount in the left lane is a half of that in the right lane. Top1/Actin, Top1 versus actin densitometry 
ratios relative to the 0 μM 4-OHT condition. (B) Efficiency of Top1 knockdown in 
BL2-AID–/–AIDER cells. Whole-cell extracts were prepared 96 hr after introducing the indicated 
siRNA against Top1 or negative control oligos. (C) Scheme for generating the Top1f and Top1– allele 
in the mouse Top1 gene locus. Pgk-neo, PGK promoter-driven neomycin-resistance gene; DT-A, 
diphtheria toxin A; Probe A, Southern blot probe for genotyping; H, HindIII site. (D) Southern blot 
showing the Top1 f/+ allele and wild-type (Top1+/+) genotypes. Tail DNA was digested with HindIII 
and probed with Probe A shown in C. (E) Top1 protein levels in spleen B cells from Top1+/+ and 
heterozygote (Top1–/+) littermates. Antibodies were the same as in A. The Top1/Actin ratios were 
normalized to the rightmost lane of Top1+/+. 
 
Figure 2. Top1 level inversely correlates with SHM frequency 
(A) Western blot of Top1 (top panel), AIDER (2nd), GFP (3rd), and tubulin (lowest) proteins of 
parental P388 cells and their sublines, which include P388-AIDER, P388/CPT45-AIDER, and its 
stable transfectant with GFP or GFP-hTop1. Three different sizes of Top1 are indicated by arrows: 
arrow 1, endogenous Top1 (~100 kDa); arrow 2, P388/CPT45-specific Top1 (~135 kDa); arrow 3, 
GFP-hTop1 (~130 kDa); arrow 4, endogenous AID; arrow 5, AID-ER. Size marker positions are 
indicated at right. Triangle shows that two lanes of each sample have different protein amounts with 
the ratio of 2 to 3 on the left versus right lane. (B) Quantitative RT-PCR of the μ germinal transcripts 
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in P388 parental, P388/CPT45 subclones, and CH12 cells. (C) Proliferation curve of 
P388/CPT45-AIDER cells expressing the GFP (circle) or GFP-hTop1 (rectangle) protein. 
 
Figure 3. SHM augmentation by Top1 knockdown depends on target transcription 
(A) AIDER expression in NTZ-AIDER cells. The amount of protein loaded per lane was monitored 
using an anti-tubulin antibody. (B) Top1 protein levels after knockdown by the indicated siRNA 
oligos in NTZ-AIDER cells transfected with the indicated oligos and incubated for 24 hours. Cells 
were stimulated with 1 μM 4-OHT for a further 72 hours. Each sample was loaded in two lanes and 
the loaded protein amount in the left lane is a half of that in the right lane. (C) GFP reversion 
frequency after AIDER activation in Top1-knockdown cells and those transfected with control oligos. 
(D) GFP reversion frequency in a tet dilution series to decrease target transcription in 
Top1-knockdown NTZ-AIDER cells. The NTZ-AIDER cells were placed in different concentrations 
of tet on day 0, and transfected with siRNA oligos on day 1. 4-OHT was added on day 2, and SHM 
was evaluated on day 6. 
 
Figure 4. Top1 inhibitor CPT suppresses SHM 
(A) GFP reversion assay of NTZ-AIDER cells stimulated with 1 μM 4-OHT for 3 days in the 
presence or absence of 30 nM CPT. (B) Percentages of propidium iodide (PI)-negative live cells in 
the samples analyzed in A. (C) Quantification of GFP transcripts in the cell populations analyzed in 
A. The Q-PCR signals of GFP mRNA were normalized to the β-actin mRNA signal. (D) Western 
blots of the Top1 protein 3 hours after the activation of JP8BdelER in BL2 cells. Top1/actin, signal 
intensity ratio of Top1 versus actin protein. 4-OHT stimulated sample was loaded in two lanes, and 






Table 1. SHM frequency in the V and Sμ regions in 





Mutation rate (× 10-4) 
(mutated/total bases) 
A. 100 hTop1#3  18 / 189 2.7a (21 / 78,624) 
 control  13 / 197 1.6b (13 / 81,952) 
   0 hTop1#3   2 / 126 0.4c (2 / 52,416) 
 control   3 / 140 0.5d (3 / 58,240) 
B. 100 hTop1#3  27 / 69 5.3e (59 / 112,263) 
 control  28 / 74 3.5f (42 / 120,398) 
   0 hTop1#3   6 / 42 1.0g (7 / 68,334) 
 control   6 / 35 1.2h (7 / 56,945) 
C. Litter genotype 
 (wks) Top1 
#1 (20) + / – 34 / 75 125i (467 / 37,500) 
 + / + 22 / 69  44j (152 / 34,000) 
     
#2 (16) + / – 22 / 23 317k (365 / 11,500) 
 + / + 14 / 23 131l (165 / 11,500) 
     
#3 (25) + / – 31 / 44 219m (482 / 22,000) 
 + / +  6 / 17  93n (79 / 8,500) 
 + / +  7 / 12 126o (76 / 6,000) 
A, B. BL2 AID–/– AIDER cells were incubated for 3 days with 
4-OHT. The 416-bp-long re-arranged VH4-39-JH5 region (33) 
and the 5’ end of the Sμ core region cloned by hSμ-A and 
hSμ-D (1,627 bp) (54) were sequenced, in A and B, 
respectively. C. Germinal center B cells from Peyer’s patches 
of Top1 heterozygote and wild-type littermates were 
recovered. The 500-bp 3’ end of the JH4 region (55) was 
analyzed. Deletion and insertion numbers are shown in Table 
S3-S6 and not counted in the mutation rates throughout the 
present study. p-value by Fisher's exact test: a vs. b, 9.3 x 10-2; 
b vs. c, 4 x 10-5; b vs. d, 5.1 x 10-2; e vs. f, 3 x 10-2; e vs. g, 7 x 
10-7; f vs. h, 3.8 x 10-3; i vs. j, 2.5 x 10-32; k vs. l, 4.4 x 10-19; m 
vs. n, 3.2 x 10-15 ; m vs. o, 1.2 x 10-6  
 
Table 2. SHM in the Sμ region in P388 cells 
Cells 4-OHT (μM) 
Mutated 
/clones 
Mutation rate (× 10-4) 
(mutated/total bases) 
A. P388- AIDER 1 11 / 143 0.71a (11 / 155,012)
 0 4 / 154 0.36  (6 / 166,936)
  P388/CPT45 1 31 / 144 2.56b (39 / 156,096)
     -AIDER 0 4 / 149 0.25c (4 / 161,516)
B. P388/CPT45 
   -AIDER  1 24 / 89 6.3
d (35 / 55,981)
   with GFP 0  2 / 93 0.5e (3 / 58,497)
  P388/CPT45 
   -AIDER 1  9 / 81 2.2
f (11 / 50,949)
   with    
   GFP-hTop1 0  4 / 92 0.7
g (4 / 57,868)
A. P388-AIDER and P388/CPT45-AIDER cells were 
stimulated with 4-OHT for 7 days. The 1,084-bp Iμ/Sμ region 
(9) amplified by mSμA-mSμD was sequenced. B. Cells were 
stimulated as in A. The 629-bp segment between 
mSμB-mSμD was analyzed. p-value by Fisher’s exact test: a 
vs. b, 5 x 10-5; b vs c, 8.4 x 10-9; d vs. f, 8 x 10-4; d vs. e, 1.6 x 
10-8; f vs. g, 0.03 
 





Mutation rate (× 10-3) 
(mutated/total bases) 
1 mTop1#35 23 / 28 4.5a  (111 / 24,836) 
 mTop1#97 28 / 30 4.7b  (124 / 26,610) 
 control 24 / 29 2.9c   (76 / 25,723)  
    
0 mTop1#35  3 / 31 0.11d   (3 / 27,497)  
 mTop1#97  6 / 30 0.23e   (6 / 26,610)  
 control  1 / 31 0.04f   (1 / 27,497) 
NTZ cells transfected with siRNA oligos were incubated 
with 4-OHT for 3 days. The GFP region was sequenced (37). 
p-value by Fisher’s exact test: a vs. c, 3×10–3; b vs. c, 
4×10–4; a vs. d, 3 x 10–32; b vs. e, 3 x 10–31 ; c vs. f, 3.8 x 
10–23; d vs. f, 0.3; e vs. f, 0.057 
 







Mutation rate (× 10-4) 
(mutated/total bases) 
A. 0 0 7 / 83 0.95 (7 / 73,621) 
1 0 26 / 84 6.1a (46 / 74,508) 
0 30  1 / 88 0.13b (1 / 78,056) 
1 30 12 / 90 1.5c (12 / 79,830) 
B. 0 0 6 / 54 1.7 (8 / 46,008) 
1 0 33 / 81 7.2d (50 / 69,012) 
1 30 22 / 98 3.5e (29 / 83,496) 
A. Genomic DNA was recovered from NTZ-AIDER cells 
exposed to 30 nM CPT for 3 days together with 4-OHT, 
and the GFP gene was sequenced (37).  
B. BL2-JP8BdelER cells were exposed to 30 nM CPT for 
25 hours together with 4-OHT for the last 24 hours. The 5’ 
region of Sμ amplified with hSμ-B and hSμ-D (852 bp) 
was sequenced. p-value by Fisher’s exact test; a vs. c, 1.2 x 
10–6; b vs. c, 1.9×10–3; d vs. e, 9.5 x 10–4 
 
